Literature DB >> 15378351

Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome.

Yoshihiro Maruo1, Carlos D'Addario, Asami Mori, Masaru Iwai, Hiroko Takahashi, Hiroshi Sato, Yoshihiro Takeuchi.   

Abstract

Gilbert syndrome is a mild hereditary unconjugated hyperbilirubinemia caused by mutations in the bilirubin UDP-glucuronosyltransferase gene (UGT1A1). The mutation, A(TA)7TAA, is thought to be the sole cause of the syndrome in Caucasians, but an enhancer polymorphism (T-3279G) that lowers transcriptional activity has recently been reported. We have tested the linkage of the two mutations in 11 Caucasians and 12 Japanese patients who were homozygous for A(TA)7TAA. All 23 patients were also homozygous for T-3279G, indicating that T-3279G and A(TA)7TAA were linked. The decrease in transcription caused by both mutations together may be essential to the syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378351     DOI: 10.1007/s00439-004-1183-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.

Authors:  Junko Sugatani; Kasumi Yamakawa; Kouich Yoshinari; Takashi Machida; Hitoshi Takagi; Masatomo Mori; Satoru Kakizaki; Tatsuya Sueyoshi; Masahiko Negishi; Masao Miwa
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

2.  Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism.

Authors:  Y Maruo; K Nishizawa; H Sato; Y Doida; M Shimada
Journal:  Pediatrics       Date:  1999-06       Impact factor: 7.124

3.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

4.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Authors:  P J Bosma; J R Chowdhury; C Bakker; S Gantla; A de Boer; B A Oostra; D Lindhout; G N Tytgat; P L Jansen; R P Oude Elferink
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245

  4 in total
  19 in total

1.  Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice.

Authors:  Yoshihiro Maruo; Yoriko Morioka; Hiroshi Fujito; Sayuri Nakahara; Takahide Yanagi; Katsuyuki Matsui; Asami Mori; Hiroshi Sato; Robert H Tukey; Yoshihiro Takeuchi
Journal:  J Pediatr       Date:  2014-03-17       Impact factor: 4.406

2.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

3.  Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients.

Authors:  Akitaka Nomura; Yoshihiro Maruo; Takashi Taga; Yoshihiro Takeuchi
Journal:  Pediatr Res       Date:  2016-04-08       Impact factor: 3.756

4.  Coexistence of gilbert syndrome and hereditary spherocytosis in a child presenting with extreme jaundice.

Authors:  Jae Hee Lee; Kyung Rye Moon
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-12-31

5.  Effects of UDP-glucuronosyltransferase polymorphisms on the pharmacokinetics of ezetimibe in healthy subjects.

Authors:  Jung-Woo Bae; Chang-Ik Choi; Jin-Hee Lee; Choon-Gon Jang; Myeon-Woo Chung; Seok-Yong Lee
Journal:  Eur J Clin Pharmacol       Date:  2010-09-24       Impact factor: 2.953

6.  Combined effect of regulatory polymorphisms on transcription of UGT1A1 as a cause of Gilbert syndrome.

Authors:  Katsuyuki Matsui; Yoshihiro Maruo; Hiroshi Sato; Yoshihiro Takeuchi
Journal:  BMC Gastroenterol       Date:  2010-06-08       Impact factor: 3.067

7.  Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.

Authors:  Jing-Ping Lin; Johannes P Schwaiger; L Adrienne Cupples; Christopher J O'Donnell; Gang Zheng; Veit Schoenborn; Steven C Hunt; Jungnam Joo; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

8.  Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter.

Authors:  Junko Sugatani; Kousuke Mizushima; Makoto Osabe; Kasumi Yamakawa; Satoru Kakizaki; Hitoshi Takagi; Masatomo Mori; Akira Ikari; Masao Miwa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

9.  Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver.

Authors:  Ye Li; David Buckley; Shuang Wang; Curtis D Klaassen; Xiao-bo Zhong
Journal:  Drug Metab Dispos       Date:  2009-06-18       Impact factor: 3.922

Review 10.  Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Yoshihiro Maruo; Shujuan Chen; Robert H Tukey
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-02       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.